UnknownNot Applicable

High Flow Nasal Cannula and Conventional Oxygen Therapy in the Postoperative Management of Patients With Mild to Moderate Obstructive Sleep Apnea

Egypt60 participantsStarted 2024-03-16

Plain-language summary

This study aims to compare the effectiveness of conventional oxygen therapy oxygen and high-flow nasal cannula therapy on oxygen saturation (SpO2), measuring number of SpO2 drop \>4% of base line oxygen saturation (o2 desaturation index), length of the ICU stay, and the need of use supplemental continuous positive airway pressure (CPAP) support in any of the study groups in the postoperative ICU setting.

Who can participate

Age range21 Years – 40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age group from 21 - 40 years old. * Both sexes. * Mild to moderate obstructive sleep apnea (OSA) patients with STOP-BANG score less than 5. * OSA patients undergoing non cardiac surgeries. * Patients who will undergo scheduled elective surgeries under general anesthesia. Exclusion Criteria: * Patient refusal of procedure or participation in the study. * Patients with severe OSA, STOP-BANG score more than or equal 5. * Patients dependent on home ventilation CPAP or bilevel devices. * Pregnant females. * Post cardiac or thoracic surgery patients. * More than American Society of Anesthesiologists (ASA) II patients. * Head and face trauma patients.

What they're measuring

Oxygen desaturation index

Timeframe: During intensive care unit stay (assessed up to day 5)

Trial details

NCT IDNCT06306651

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-01

Contact for this trial

Omar M Mohamed, Master

00201063190923 omarmedhat0100565@med.asu.edu.eg

View on ClinicalTrials.gov More High Flow Nasal Cannula trials